DIMENSIONAL FUND ADVISORS LP

Position in FTRE — Fortrea Holdings Inc.

CIK 354204 AUSTIN, TX

Position in FTRE

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$12,244,698

+$3,744,227 QoQ

Shares Held

1,299,862

+163.8% QoQ

Ownership

1.37%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 90.38167128510565.ToString("F0")% Shared 6.389062838978292.ToString("F0")% None 3.229265875916059.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. FTRE ranks #64 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,244,698	1,299,862	+163.8%	Shares	Sole	2026-05-07
2025-12-31	$8,500,471	492,781	-16.7%	Shares	Sole	2026-02-12
2025-09-30	$4,981,406	591,616	-14.2%	Shares	Sole	2025-11-12
2025-06-30	$3,408,045	689,888	-20.2%	Shares	Sole	2025-08-12
2025-03-31	$6,527,176	864,527	-4.3%	Shares	Sole	2025-05-13
2024-12-31	$16,842,329	903,074	-1.5%	Shares	Sole	2025-02-13
2024-09-30	$18,338,920	916,946	-1.8%	Shares	Sole	2024-11-07
2024-06-30	$21,799,208	933,985	+4.8%	Shares	Sole	2024-08-09
2024-03-31	$35,757,070	890,809	-0.1%	Shares	Sole	2024-05-10
2023-12-31	$31,130,832	892,001	-30.5%	Shares	Sole	2024-02-07
2023-09-30	$36,717,906	1,284,292	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.